Oxbryta Recall Announced After Studies Show Sickle Cell Drug’s Risks Outweigh Benefits
Pfizer is recalling Oxbryta after at least eight patients died during clinical trials, which sparked a safety review by European drug regulators.
September 26, 2024 By: Martha Garcia
Pfizer is recalling Oxbryta after at least eight patients died during clinical trials, which sparked a safety review by European drug regulators.
A Kentucky man's lawsuit claims Ozempic and Rybelsus side effects led to multiple trips to the emergency room due to nausea, vomiting and other reactions to his intestinal muscles being unable to push food through his digestive tract.
Lawyers will be meeting with the MDL judge presiding over all Suboxone tooth decay lawsuits on October 4 and 5, 2024, to finalize information needed to select a group of representative cases for bellwether discovery and trial.
Lawyers have reached a confidential settlement agreement to resolve tens of thousands of Bard hernia mesh lawsuits after six years of litigation, but individuals must still agree to participate and settle their claims.
"*" indicates required fields